Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
Crossref DOI link: https://doi.org/10.1007/s11095-018-2436-z
Published Online: 2018-05-31
Published Print: 2018-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salmikangas, Paula
Kinsella, Niamh
Chamberlain, Paul
Text and Data Mining valid from 2018-05-31
Article History
Received: 3 April 2018
Accepted: 23 May 2018
First Online: 31 May 2018